We use cookies to study and improve the user experience offered by the site. By continuing to browse the site you are agreeing to our cookie policy.

News

Dr.Manel Juan
03/22/2016

Dr. Manel Juan, expert in immunology, visits the Josep Carreras Leukaemia Research Institute

"There are many challenges. Obviously the main one is to expand the success of CART19 to other CARTs, especially for lymphomas. It is also important to control their side effects and, as in all complicated and expensive therapies, another important challenge is to find a way of making them available to everyone who needs them without that availability depending on the financial resources or location of the people concerned."

More
03/09/2016

Dr.Rafael Béjar, a world expert in the study of myelodysplastic syndromes (MDS), visits the Josep Carreras Leukaemia Research Institute

"Treatment for patients with MDS is becoming more and more personalised. In the coming years we are going to see more emphasis on the genetic mutations associated with MDS. Every patient has a different pattern of mutations and these mutations can be used to indicate how the patient should be treated. The mutations can be used to establish the diagnosis, determine the prognosis and to predict which therapies will be the most efficacious."

More
Equpo Pablo Menéndez Campus Clínic IJC
03/03/2016

New scientific paper about lymphoblastic leukaemia with MLL-AF4 fusion

MLL-AF4 translocation is the genetic marker that characterises acute lymphoblastic leukaemia B (ALL-B) which is especially aggressive, commonly affects children under the age of one, and which responds poorly to treatment with chemotherapy, survival rates for this disease being less than 30%.

 

More
Alejandra Sanjuan
12/15/2015

The Stem Cell, Mesenchymal Cancer and Development Group has published a new scientific article on infantile acute lymphoblastic leukaemia in cells t (4; 11) / MLL-AF4 + B in the prestigious journal Blood

This particular article, under the direction of Dr. Sanjuan-Pla, focuses on what is known about this form of leukaemia, some of the particular characteristics of studying a disease that appears in such young patients, and goes on to mention what the group hopes will be the result of the application of new technologies in this field of research. 

More
Webpage updated 10/16/2019 13:23:15